{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:32:20Z","timestamp":1772235140420,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473535"],"award-info":[{"award-number":["81473535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polyglucosan body myopathy 1 (PGBM1) is a type of glycogen storage disease that can cause skeletal muscle myopathy and cardiomyopathy with or without immunodeficiency due to a pathogenic mutation in the RBCK1 gene. PGBM1 has been reported in only 14 European and American families, and no cognitive impairment phenotype was reported. Its prevalence in Asia is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation:<\/jats:title>\n                <jats:p>We report a Chinese boy with teenage onset of skeletal muscle myopathy and mild cognitive impairment. Whole-exome sequencing analysis identified a homozygous missense mutation in RBCK1 (c.1411G\u2009&gt;\u2009A:p.Glu471Lys). A muscle biopsy indicated the accumulation of periodic acid-Schiff-positive material, which could be ubiquitinated by immunohistochemistry with an anti-ubiquitin antibody. In skeletal muscle tissue, HOIL-1 and HOIP protein levels were lower than those in the control, confirming the phenotype of an RBCK1 mutation. MRI revealed abnormal cerebral white matter signals. Immune system and cardiac examination found no abnormalities. The patient was diagnosed with PGBM1 with no effective treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case from China with a novel homozygous missense mutation in RBCK1 extends the phenotypic spectrum and geographical distribution of PGBM 1, which may cause cerebral white matter changes and cognitive impairment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-020-03884-0","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T07:03:51Z","timestamp":1610003031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8720-9987","authenticated-orcid":false,"given":"Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-7176","authenticated-orcid":false,"given":"Wenbin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Nian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congbo","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"3884_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mam.2015.08.006","volume":"46","author":"C Hedberg-Oldfors","year":"2015","unstructured":"Hedberg-Oldfors C, Oldfors A. Polyglucosan storage myopathies. Mol Aspects Med. 2015;46:85\u2013100.","journal-title":"Mol Aspects Med"},{"key":"3884_CR2","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/ana.23963","volume":"74","author":"J Nilsson","year":"2013","unstructured":"Nilsson J, Schoser B, Laforet P, et al. Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1. Ann Neurol. 2013;74:914\u20139.","journal-title":"Ann Neurol"},{"key":"3884_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/brain\/103.2.315","volume":"103","author":"Y Robitaille","year":"1980","unstructured":"Robitaille Y, Carpenter S, Karpati G, DiMauro SD. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora\u2019s disease and normal ageing. Brain. 1980;103:315\u201336.","journal-title":"Brain"},{"key":"3884_CR4","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/ni.2457","volume":"13","author":"B Boisson","year":"2012","unstructured":"Boisson B, Laplantine E, Prando C, et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol. 2012;13:1178\u201386.","journal-title":"Nat Immunol"},{"key":"3884_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","volume":"86","author":"N Zheng","year":"2017","unstructured":"Zheng N, Shabek N. Ubiquitin Ligases: Structure, Function, and Regulation. Annu Rev Biochem. 2017;86:129\u201357.","journal-title":"Annu Rev Biochem"},{"key":"3884_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00415-017-8710-x","volume":"265","author":"M Krenn","year":"2018","unstructured":"Krenn M, Salzer E, Simonitsch-Klupp I, et al. Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum. J Neurol. 2018;265:394\u2013401.","journal-title":"J Neurol"},{"key":"3884_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/gm471","volume":"5","author":"K Wang","year":"2013","unstructured":"Wang K, Kim C, Bradfield J, et al. Whole-genome DNA\/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement. Genome Med. 2013;5:67.","journal-title":"Genome Med"},{"key":"3884_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1128\/MCB.01538-13","volume":"34","author":"H Fujita","year":"2014","unstructured":"Fujita H, Rahighi S, Akita M, et al. Mechanism underlying IkappaB kinase activation mediated by the linear ubiquitin chain assembly complex. Mol Cell Biol. 2014;34:1322\u201335.","journal-title":"Mol Cell Biol"},{"key":"3884_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/embor.2009.144","volume":"10","author":"K Iwai","year":"2009","unstructured":"Iwai K, Tokunaga F. Linear polyubiquitination: a new regulator of NF-kappaB activation. EMBO Rep. 2009;10:706\u201313.","journal-title":"EMBO Rep"},{"key":"3884_CR10","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353.","journal-title":"Nat Med"},{"key":"3884_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ncb1821","volume":"11","author":"F Tokunaga","year":"2009","unstructured":"Tokunaga F, Sakata S, Saeki Y, et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol. 2009;11:123\u201332.","journal-title":"Nat Cell Biol"},{"key":"3884_CR12","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195\u2013224.","journal-title":"Genes Dev"},{"key":"3884_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1084\/jem.20141130","volume":"212","author":"B Boisson","year":"2015","unstructured":"Boisson B, Laplantine E, Dobbs K, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939\u201351.","journal-title":"J Exp Med"},{"key":"3884_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.nmd.2015.01.015","volume":"25","author":"I Colombo","year":"2015","unstructured":"Colombo I, Pagliarani S, Testolin S, et al. Adult polyglucosan body disease: clinical and histological heterogeneity of a large Italian family. Neuromuscul Disord. 2015;25:423\u20138.","journal-title":"Neuromuscul Disord"},{"key":"3884_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.23598","volume":"72","author":"F Mochel","year":"2012","unstructured":"Mochel F, Schiffmann R, Steenweg ME, et al. Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings. Ann Neurol. 2012;72:433\u201341.","journal-title":"Ann Neurol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-020-03884-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T07:11:10Z","timestamp":1610003470000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-03884-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3884"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-03884-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies were approved by the Ethics Committee of the Anhui University of Chinese Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication and any accompanying photographs and images have been written by the participants and their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}